Pharvaris N.V. 4

Lu Peng, Chief Medical Officer of Pharvaris N.V., had 226 shares of common stock withheld for taxes related to RSU vesting at about $35.07 per share, reducing direct holdings to 65,405 shares.

On July 11 and July 12, 2026, Lu Peng, Chief Medical Officer of Pharvaris N.V., had a total of 226 shares of common stock withheld by the company to cover tax obligations arising from the vesting of restricted stock units, at an implied price of approximately $35.07 per share. These transactions, coded as Form 4 transaction type “F,” are non-open-market, administrative events rather than discretionary purchases or sales. Following these tax-withholding events, Peng’s direct ownership decreased modestly to 65,405 shares of Pharvaris common stock, with the implied incremental value of the withheld shares around $7,925 based on the indicated price. The transactions reflect routine equity compensation processing rather than a change in investment stance.

Filing Facts

CIK

1830487

Ticker

PHVS

Form

4

Source Type

fda

Accession

0001193125-26-303097

Alert Tier

4